Figure 3.
Biodistribution of 111In-basiliximab at 72 hours (left) and 18F-FDG-PET (right). There is positive uptake in right external iliac/obturator and right inguinal areas as seen on the basiliximab scan but there was no 18FDG uptake in the area.
Biodistribution of 111In-basiliximab at 72 hours (left) and 18F-FDG-PET (right). There is positive uptake in right external iliac/obturator and right inguinal areas as seen on the basiliximab scan but there was no 18FDG uptake in the area.
